Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity ISLAND PHARMACEUTICALS LIMITED ABN/ARBN Financial year ended: 48 641 183 842 30 JUNE...
Appendix 4G and Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Island Pharmaceuticals Ltd on 6ix
Earlier from Island Pharmaceuticals
- Annual Report to shareholders
- Preliminary Final Report
- Island boosts Galidesivir supply as Ebola surges
- Date of AGM & Closing Date for Director Nominations
- Cleansing Notice
Later from Island Pharmaceuticals
- Pivotal Marburg data secured for Galidesivir FDA pathway
- Annual General Meeting - Rescheduled Date
- Galidesivir GMP manufacturing commences
- Notification regarding unquoted securities - ILA
- USAMRIID Marburg study advances towards dosing
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals